Prence E M, Garrett K O, Glew R H
Biochem J. 1986 Aug 1;237(3):655-62. doi: 10.1042/bj2370655.
Extraction of control human spleen glucocerebrosidase with sodium cholate and butan-l-ol reversibly inactivates the enzyme in terms of its ability to hydrolyse the water-soluble substrate 4-methylumbelliferyl beta-D-glucopyranoside (MUGlc). The acidic brain lipid galactocerebroside 3-sulphate (sulphatide) reconstitutes beta-glucosidase activity in a strongly concentration-dependent manner. In this study we show that sulphatide exhibits three critical micellar concentrations (CMCs): CMC1, 3.72 microM; CMC2, 22.6 microM; CMC3, 60.7 microM. We designate the aggregates formed at these CMCs as primary, secondary and tertiary micelles respectively. From the results of kinetic studies performed at various sulphatide concentrations (0.012-248 microM), we found that sulphatide monomers (less than 3 microM) decreased the Km (for MUGlc) of control glucocerebrosidase from 11 to 4.6 mM, and lowered the Vmax. 2-fold. However, secondary and tertiary micelles were required for expression of high control glucocerebrosidase activities. Glucocerebrosidase prepared from the spleen of a patient with non-neuronopathic type 1 Gaucher's disease exhibited a very low Km (2.8 mM) even in the absence of exogenous lipid, and sulphatide monomers had no effect on the mutant enzyme's Km or Vmax. However, secondary or tertiary micelles markedly increased the Vmax. of the type 1 glucocerebrosidase to 60% of the corresponding control enzyme value. In contrast, for the glucocerebrosidase of the neuronopathic type 2 case, although sulphatide decreased the Km from 9.2 to 1.7 mM, the Vmax. never reached more than 5% that of the control enzyme, even at high concentrations of sulphatide. In addition, we found that secondary and tertiary sulphatide micelles enhanced the rate of inactivation of all three glucocerebrosidase preparations by chymotrypsin. Collectively, these results indicate the presence of two sulphatide-binding sites on glucocerebrosidase: one that enhances substrate binding, and another that enhances catalysis.
用胆酸钠和正丁醇提取正常人脾脏的葡萄糖脑苷脂酶,就其水解水溶性底物4 - 甲基伞形酮基β - D - 吡喃葡萄糖苷(MUGlc)的能力而言,该酶会发生可逆性失活。酸性脑脂质半乳糖脑苷脂3 - 硫酸盐(硫脂)以强烈的浓度依赖性方式重构β - 葡萄糖苷酶活性。在本研究中,我们表明硫脂呈现出三个临界胶束浓度(CMC):CMC1为3.72微摩尔/升;CMC2为22.6微摩尔/升;CMC3为60.7微摩尔/升。我们将在这些CMC下形成的聚集体分别称为初级、次级和三级胶束。从在不同硫脂浓度(0.012 - 248微摩尔/升)下进行的动力学研究结果来看,我们发现硫脂单体(浓度低于3微摩尔/升)可使正常人葡萄糖脑苷脂酶的Km(对MUGlc而言)从11毫摩尔/升降至4.6毫摩尔/升,并使Vmax降低2倍。然而,高活性的正常人葡萄糖脑苷脂酶的表达需要次级和三级胶束。从非神经元型1型戈谢病患者脾脏中制备的葡萄糖脑苷脂酶,即使在没有外源脂质的情况下,其Km也非常低(2.8毫摩尔/升),并且硫脂单体对突变酶的Km或Vmax没有影响。然而,次级或三级胶束可使1型葡萄糖脑苷脂酶的Vmax显著增加至相应对照酶值的60%。相比之下,对于神经元型2型病例的葡萄糖脑苷脂酶,尽管硫脂可使Km从9.2毫摩尔/升降至1.7毫摩尔/升,但即使在高浓度硫脂存在的情况下,Vmax也从未超过对照酶的5%。此外,我们发现次级和三级硫脂胶束会提高所有三种葡萄糖脑苷脂酶制剂被胰凝乳蛋白酶失活的速率。总体而言,这些结果表明葡萄糖脑苷脂酶上存在两个硫脂结合位点:一个增强底物结合,另一个增强催化作用。